Utah Admin. Code R156-37-102 - Definitions
Terms used in this rule are defined in Title 58, Chapter 1, Division of Professional Licensing Act, and Title 58, Chapter 37, Utah Controlled Substances Act. In addition:
(1) "DEA" means the Drug Enforcement
Administration of the United States Department of Justice.
(2) "Electronic Controlled Substance
Prescribing Extension" means the prescribing practitioner or pharmacy has a
controlled substance designation class indicated on the license, approved by
the Division under Section
R156-37-610, and does not
participate in electronic prescriptions for controlled substances.
(3) "Emergency situation" for purposes of
Subsection
58-37-6(7)(c)(iii)
and Section R156-37-605 for emergency verbal
prescriptions, Subsection
58-37-6(7)(d) for
prescription signature and information requirements, and Subsection
58-37-22(1)(e)
for electronic prescription requirements:
(a)
means a situation in which the prescribing practitioner who intends to
prescribe a controlled substance, or the pharmacy that intends to dispense a
controlled substance, has determined that:
(i)
the controlled substance prescription cannot be issued, filled, compounded,
dispensed, or transmitted electronically as an electronic prescription in
compliance with the statutory requirement without causing a delay;
(ii) the delay would adversely impact the
patient's medical condition; and
(iii) the prompt prescribing or dispensing of
the controlled substance is necessary for the proper treatment of the patient;
and
(b) includes a
situation when a prescription is written for an emergent or urgent condition:
(i) at a time when the prescribing
practitioner is not reasonably able to transmit an electronic prescription to
the patient's desired pharmacy for dispensing; or
(ii) after normal pharmacy business hours
including weekends, holidays, late evening or overnight, and the patient cannot
fill the prescription secondary to limited access to 24-hour pharmacy locations
and no access to their regular pharmacy.
(4) "Forward" in Subsection
R156-37-609(4)(a)
means an original unfilled electronic controlled substance
prescription.
(5) "NABP" means the
National Association of Boards of Pharmacy.
(6) "Principal place of business or
professional practice" in Subsection
58-37-6(2)(e),
means any location where controlled substances are received or
stored.
(7) "Schedule II controlled
stimulant" means any material, compound, mixture, or preparation listed in
Subsection
58-37-4(2)(b)(iii).
(8) "SBIRT training" means training in the
Screening, Brief Intervention, and Referral to Treatment approach used by the
federal Substance Abuse and Mental Health Services Administration, as defined
in Subsection
58-37-6.5(1)(e).
(9) "Technical difficulty or electronic
failure" in Subsection
58-37-22(1)(d)
means a loss of electrical power or internet service, a failure of a computer
system, application, or device, or other service interruption to a computer
system that reasonably prevents:
(a) a
practitioner from transmitting an electronic controlled substance prescription
to a pharmacy;
(b) a pharmacy from
receiving an electronic controlled substance prescription or transmitting an
electronic controlled substance prescription to a different pharmacy in
accordance with Subsection
58-37-22(3);
or
(c) compliance by a practitioner
or a pharmacy with the requirements of state or federal law, including 21 CFR
Part 1311 (April 1, 2024), which is incorporated by reference.
(10) "Unprofessional conduct" as
defined in Title 58, Occupations and Professions, is further defined in
accordance with Subsections
58-1-203(1)(e)
and 58-37-6(1)(a), in
Section R156-37-502.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.